News
Zydus announces conclusion of USFDA inspection of LiqMeds, UK
14-Nov-2026 | 13:57
Zydus Lifesciences announced that the USFDA conducted an inspection at LiqMeds, UK. The inspection was conducted from 9 to 13 November, 2026 and concluded with 4 observations. The Company will closely work with the USFDA to address the observations expeditiously.